N@N

Market Maker Surveillance Report. TZOO, PURE, AEZS, INPH, XNPT, FMNL, Losing Stocks With Lowest Price Friction For Friday, Oct

October 12, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 3780 companies with "abnormal" market making, 1957 companies with positive Friction Factors and 3263 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Friday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Travelzoo Inc (NASDAQ:TZOO), Pure Bioscience (NASDAQ:PURE), AETERNA ZENTARIS INC (NASDAQ:AEZS), Interphase Corp (NASDAQ:INPH), Xenoport Inc (NASDAQ:XNPT), Forum National Investments Ltd (OTC:FMNL). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  TZOO    $-3.480   -14.81%   376,586      45.90%    421,671      51.39%    -45,085      -130    
  PURE    $-0.160   -10.19%   483,228      48.38%    507,471      50.80%    -24,243      -1,515  
  AEZS    $-0.690   -22.12%   2,946,906    48.69%    3,105,266    51.31%    -158,360     -2,295  
  INPH    $-0.290   -9.06%    31,275       33.33%    62,552       66.67%    -31,277      -1,079  
  XNPT    $-1.260   -10.58%   288,701      41.48%    380,045      54.60%    -91,344      -725    
  FMNL    $-0.150   -9.09%    51,000       48.20%    54,804       51.80%    -3,804       -254    

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar losses (Change) and extremely low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows TZOO with a dollar loss Friday of $-3.48000 and a Friction Factor of -130 shares. That means that it only took 130 more shares of selling than buying to move TZOO lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

Travelzoo Inc (NASDAQ:TZOO) - Travelzoo Inc., an Internet media company, publishes travel and entertainment offers from various travel and entertainment companies in North America and Europe. The companys publications and products include the Travelzoo Web sites, including travelzoo.com, travelzoo.ca, travelzoo.co.uk, travelzoo.de, travelzoo.es, and travelzoo.fr; the Travelzoo Top 20 e-mail newsletter; and the Newsflash e-mail alert service. It also offers the SuperSearch pay-per-click travel search tool; and the Travelzoo Network, a network of third-party Web sites that list deals published by Travelzoo. In addition, the company operates Fly.com, a travel search engine that allows users to find the best prices on flights from various airlines and online travel agencies. Its products provide advertising opportunities for airlines, hotels, cruise lines, vacation packagers, and other travel and entertainment companies. Travelzoo Inc. was founded in 1998 and is headquartered in New York, New York..

Pure Bioscience (NASDAQ:PURE) - Pure Bioscience, Inc. engages in the development and commercialization of bioscience technologies principally in the United States. The company offers silver dihydrogen citrate (SDC) based antimicrobials. The silver dihydrogen citrate technology is an electrolytically generated source of stabilized ionic silver that could serve as the basis for various products in diverse markets. It also produces SDC as an active pharmaceutical ingredient, which is in clinical trials for multiple indications. In addition, the company provides Axen and Axen30 hard surface disinfectant products for commercial, industrial, and consumer applications, including restaurants, homes, and medical facilities; Axen50 food contact surface sanitizer for sanitization of food contact surfaces and equipment in environments, such as farms, food processing plants, schools, hospitals, restaurants, and homes; and SDC3A disinfectant and food contact surface sanitizer. In addition, it offers SDC-based antimicrobial product; and concentrated SDC-based water treatment product. Pure Bioscience, Inc. sells its products through partners and distributors primarily to industrial and consumer markets. The company was formerly known as Innovative Medical Services and changed its name to Pure Bioscience, Inc. Pure Bioscience, Inc. was founded in 1992 and is headquartered in El Cajon, California..

AETERNA ZENTARIS INC (NASDAQ:AEZS) - terna Zentaris Inc. operates as a late-stage drug development company specialized in oncology and endocrinology. Its lead oncology compounds include perifosine, an orally active PI3K/Akt pathway inhibitor that is in Phase III registration trial for multiple myeloma; and AEZS-108, a doxorubicin-targeted conjugate in Phase II for the treatment of advanced ovarian and endometrial cancer. The companys lead endocrinology compound, AEZS-130, is an oral ghrelin antagonist in Phase III trial as a diagnostic test for Adult Growth Hormone Deficiency. Its pipeline also includes earlier-stage compounds, such as AEZS-112 that is in a Phase I trial in advanced solid tumors and lymphoma, as well as AEZS-120, an anti-cancer vaccine in pre-clinical development. The company was founded in 1991 and is headquartered in Quebec City, Canada..

Interphase Corp (NASDAQ:INPH) - Interphase Corporation and its subsidiaries provide building blocks, integrated subsystems, and gateway appliances in the areas of network connectivity, content management, and packet processing solutions in the converged communications network. It delivers embedded computing solutions for network connectivity, interworking, packet processing, LTE and WiMAX base station, and security applications for the communications, aerospace/defense, and enterprise markets. The companys network connectivity products comprise T1/E1 communication controllers, OC-3/STM-1 ATM network interface cards (NICs), and Ethernet NICs; interworking products include OC-3/STM-1 interworking modules and gateway appliances; multi-core packet processors comprise GigE packet processors and 10 GigE packet processors; and wireless base station modules include LTE eNodeB modules and WiMAX base station modules. It also offers engineering design services, such as specifications gathering, program management, detailed design, and rapid prototyping; and contract manufacturing services, including branding and control, production assembly, integration, and testing and delivery. The company markets its products through direct sales force, manufacturers representatives, and value-added distribution partners. It has operations in the Pacific Rim, North America, and Europe. Interphase Corporation was founded in 1973 and is headquartered in Plano, Texas..

Xenoport Inc (NASDAQ:XNPT) - XenoPort, Inc., a biopharmaceutical company, focuses on developing internally discovered product candidates that utilize the bodys natural nutrient transport mechanisms to enhance the therapeutic benefits of drugs. The company licenses its lead product candidate XP13512, a transported prodrug of gabapentin, to Astellas Pharma Inc. in Japan and five Asian countries, as well as to Glaxo Group Limited (GSK) in the United States and internationally. Astellas and GSK filed new drug applications for the approval of XP13512 as a treatment for restless legs syndrome in Japan and the United States. The company also develops Arbaclofen Placarbil, which is under Phase IIb clinical trials for the treatment of gastroesophageal reflux disease. In addition, it develops Arbaclofen Placarbil that has completed Phase II clinical trials for the treatment of spasticity. Further, the company develops XP21279, a transported prodrug of L-Dopa, which has completed Phase I clinical trials for the treatment of Parkinsons disease; and XP21510, a transported prodrug of tranexamic acid, that is in preclinical stages for the treatment of menorrhagia or heavy menstrual bleeding. XenoPort, Inc. has strategic alliances with Astellas Pharma, Inc. and Glaxo Group Limited. The company was founded in 1999 and is based in Santa Clara, California..

Forum National Investments Ltd (OTC:FMNL) - .

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net